Loading...
•
Jan 31, 2020
Cooper Q1 2020 Earnings Report
CooperCompanies' first quarter of 2020 resulted in increased revenue and decreased GAAP and non-GAAP diluted earnings per share compared to the previous year.
Key Takeaways
CooperCompanies reported a 3% increase in revenue to $646.2 million. GAAP diluted earnings per share decreased by 12% to $1.82, and Non-GAAP diluted earnings per share decreased by 7% to $2.69.
Revenue increased 3% year-over-year to $646.2 million.
CooperVision (CVI) revenue increased 3% to $485.2 million.
CooperSurgical (CSI) revenue increased 2% to $161.0 million.
Non-GAAP diluted earnings per share was $2.69, a decrease of 7% from last year's first quarter.
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Revenue by Segment
Office & Surgical Revenue
CapyFin.comFertility Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEMEA Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
The Company updated its fiscal year 2020 guidance. Fiscal 2020 total revenue is expected to be between $2,767 - $2,817 million (~5% to 7% constant currency). CVI revenue is expected to be $2,070 - $2,100 million (~5.5% to 7% constant currency) and CSI revenue $697 - $717 million (~3% to 6% constant currency). Fiscal 2020 non-GAAP diluted EPS of $12.80 - $13.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income